0001051339-21-000002.txt : 20210414
0001051339-21-000002.hdr.sgml : 20210414
20210414114924
ACCESSION NUMBER: 0001051339-21-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210316
FILED AS OF DATE: 20210414
DATE AS OF CHANGE: 20210414
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BENARROCH GEORGES
CENTRAL INDEX KEY: 0001051339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50390
FILM NUMBER: 21824970
MAIL ADDRESS:
STREET 1: 49 AVENUE FOCH
CITY: PARIS
STATE: I0
ZIP: 75116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kyto Technology & Life Science, Inc.
CENTRAL INDEX KEY: 0001164888
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 651086538
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 13050 PALOMA ROAD
CITY: LOS ALTOS HILLS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 650-204-7896
MAIL ADDRESS:
STREET 1: 13050 PALOMA ROAD
CITY: LOS ALTOS HILLS
STATE: CA
ZIP: 94022
FORMER COMPANY:
FORMER CONFORMED NAME: KYTO BIOPHARMA INC
DATE OF NAME CHANGE: 20030912
FORMER COMPANY:
FORMER CONFORMED NAME: B TWELVE INC
DATE OF NAME CHANGE: 20020111
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-03-16
0
0001164888
Kyto Technology & Life Science, Inc.
KBPH
0001051339
BENARROCH GEORGES
49 AVENUE FOCH
PARIS
I0
75116
FRANCE
1
0
0
0
Common Shares
2021-03-16
4
M
0
181250
0.033
A
181250
D
Non-qualified Stock Option (Right to Buy)
0.033
2021-03-16
4
M
0
181250
0.033
D
2021-03-16
2021-12-16
Common Shares
181250
18750
D
George Benarroch exercised 181,250 options to purchase 181,250 common shares at $0.033 per share.
Company confirmed option exercise with share issuance to be completed when company reorganization and name changed completed
Effective April 5, 2021, Georges Benarroch ceased to be a Director of the Company. Comindus Finance Corp., of which Georges Benarroch is an Officer and Director, is an insider with more than 10% shareholding of the Company.
Georges Benarroch
2021-04-14